Filing Details
- Accession Number:
- 0001127602-20-031285
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-14 16:44:37
- Reporting Period:
- 2020-12-10
- Accepted Time:
- 2020-12-14 16:44:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
859737 | Hologic Inc | HOLX | X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) | 042902449 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1783992 | R Kevin Thornal | 250 Campus Drive Marlborough MA 01752 | Div. President, Diagnostics | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-12-10 | 7,633 | $39.96 | 40,849 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-12-10 | 7,633 | $74.00 | 33,216 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-12-10 | 9,236 | $37.64 | 42,452 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-12-10 | 9,236 | $73.99 | 33,216 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2020-12-10 | 7,633 | $0.00 | 7,633 | $39.96 |
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2020-12-10 | 9,236 | $0.00 | 9,236 | $37.64 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2025-11-05 | No | 4 | M | Direct | |
0 | 2026-12-01 | No | 4 | M | Direct |
Footnotes
- The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $73.98 to $74.01 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- This option to purchase common stock became exercisable in equal installments on each of the first four anniversaries of the grant date, November 5, 2015.
- This option to purchase common stock became exercisable in equal installments on each of the first four anniversaries of the grant date, December 1, 2016.